BUSINESS● LOWJul 14 · Jul 14, 2026, 11:33 AM
Summit to sell antibiotic to Canada’s Biossil for up to $105M
Seeking Alpha Tech
Summit plans to sell an antibiotic to Canada's Biossil in a deal potentially worth up to $105 million. This transaction represents a notable business agreement in the pharmaceutical sector.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS33m agoCEO confidence drops into negative territoryAxiosBUSINESS33m agoTesla is set to end the long wait for the next-gen RoadsterSeeking Alpha Tech